Cargando...
The impact of direct-acting antiviral therapy for hepatitis C on hepatocellular carcinoma risk.
PURPOSE OF REVIEW: Direct-acting antiviral agents (DAAs) eradicate hepatitis C virus (HCV) infection in the majority of patients. We critically evaluated the impact of DAAs on hepatocellular carcinoma (HCC) risk, a major complication of HCV infection. RECENT FINDINGS: Large cohort studies show that...
Gardado en:
| Publicado en: | Curr Hepatol Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6433385/ https://ncbi.nlm.nih.gov/pubmed/30923667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-018-0424-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|